MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury.

Li T, Yu SS, Zhou CY, Wang K, Wan YC

Open source

DOI
10.1080/1061186x.2019.1616744
Published
2020 Jan
Container
Journal of drug targeting
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/1061186x.2019.1616744,
  title = {MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury.},
  author = {Li T and Yu SS and Zhou CY and Wang K and Wan YC},
  year = {2020},
  journal = {Journal of drug targeting},
  doi = {10.1080/1061186x.2019.1616744},
  url = {https://doi.org/10.1080/1061186x.2019.1616744}
}

RIS

TY  - JOUR
TI  - MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury.
AU  - Li T
AU  - Yu SS
AU  - Zhou CY
AU  - Wang K
AU  - Wan YC
PY  - 2020
JO  - Journal of drug targeting
DO  - 10.1080/1061186x.2019.1616744
UR  - https://doi.org/10.1080/1061186x.2019.1616744
ER  - 

APA

T, L., SS, Y., CY, Z., K, W., & YC, W. (2020). MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury.. Journal of drug targeting. https://doi.org/10.1080/1061186x.2019.1616744

Source records